Biotech Values

[wbart21]

Arena phIII Mega Trial




Negotiating ploy? Perhaps,however:
1) commencement of the BLOOM Trial
2) recent 148mm shelf filing
3)250 existing cash account...
in totality suggest to me that pharmaceutical partnering interest in Lorcaserin is not as robust as suggested by management.

While impressed by the size of the program, I am shocked that they're testing only one dose(20mg).